What is DT56a (soybean extract)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DT56a-Soybean Extract: A Phytoestrogen-Rich Soy Derivative

DT56a is a specialized soybean extract that functions as a natural selective estrogen receptor modulator (SERM) with bone-forming properties and estrogenic effects on specific tissues while lacking effects on others.

Composition and Properties

DT56a is derived from soybeans (Glycine max) and contains various bioactive compounds, particularly:

  • Isoflavones: Phytoestrogens including genistein, daidzein, and glycetein
  • Soy proteins: Contains globulins (11S and 7S) that have beneficial effects on metabolism
  • Other phytochemicals: Includes saponins and various bioactive compounds

What makes DT56a unique is its selective activity profile compared to standard soy extracts:

  • It demonstrates tissue-selective estrogenic activity
  • It acts as a phyto-SERM (Selective Estrogen Receptor Modulator)
  • It shows gender-specific activity in bone cells 1

Mechanism of Action

DT56a works through several mechanisms:

  1. Selective Estrogen Receptor Binding:

    • Activates estrogen receptors in bone and vascular tissues
    • Shows minimal activity in reproductive tissues like the uterus 2
  2. Bone-Specific Effects:

    • Stimulates creatine kinase (CK) specific activity in skeletal tissues
    • Increases alkaline phosphatase (ALP) activity in human osteoblasts
    • Enhances DNA synthesis in female-derived bone cells 1
  3. Calcium Regulation:

    • Dose-dependently increases intracellular calcium levels in osteoblasts
    • Shows maximal effect at lower concentrations (10 ng/ml) 1

Clinical Applications

DT56a has been studied primarily for:

  1. Menopausal Symptom Management:

    • Helps relieve vasomotor symptoms (hot flashes)
    • Does not increase endometrial thickness, unlike traditional hormone therapy
  2. Bone Health:

    • Stimulates bone formation (not just preventing resorption)
    • Has been shown to increase bone mineral density in clinical studies 2
  3. Cardiovascular Effects:

    • May have beneficial effects on vascular tissues
    • Contains components that can help lower cholesterol 3

Important Distinctions from Regular Soy Products

DT56a differs from standard soy supplements in several ways:

  • Selective Activity: Unlike regular soy isoflavones, DT56a shows more pronounced SERM-like activity
  • Gender Specificity: Research shows it specifically stimulates female-derived osteoblasts but not male-derived cells 1
  • Antagonistic Effects: When administered with estradiol, DT56a can actually inhibit estradiol's effects in certain tissues 2

Safety Considerations

While DT56a shows promise, several caveats should be noted:

  • Cancer Risk: The American Cancer Society notes that high doses of soy phytoestrogens might theoretically increase risk of estrogen-responsive cancers in certain individuals 3
  • Breast Cancer Survivors: Should consume only moderate amounts of soy products and avoid concentrated sources 3
  • Antinutritional Factors: Like all soy products, DT56a may contain components that can interfere with nutrient absorption if not properly processed 4

Clinical Perspective

DT56a represents an interesting development in phytoestrogen research, offering potential benefits beyond traditional soy supplements. Its bone-forming properties (rather than just anti-resorptive effects) make it particularly interesting for osteoporosis management. However, as with all soy-derived products, it should be used with appropriate caution in patients with hormone-sensitive conditions.

References

Research

DT56a stimulates gender-specific human cultured bone cells in vitro.

The Journal of steroid biochemistry and molecular biology, 2006

Research

DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM).

The Journal of steroid biochemistry and molecular biology, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Implications of antinutritional components in soybean foods.

Critical reviews in food science and nutrition, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.